tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Frank Takkinen, 120 are a BUY (92.31%), 10 are a HOLD (7.69%).
Analyst Frank Takkinen, currently employed at LAKE STREET, carries an average stock price target met ratio of 46.95% that have a potential upside of 34.59% achieved within 104 days.
Frank Takkinen’s has documented 254 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RCEL, Avita Medical Ltd at 16-Jan-2026.
Analyst best performing recommendations are on COCH (ENVOY MEDICAL).
The best stock recommendation documented was for NOTV (INOTIV) at 5/16/2024. The price target of $2 was fulfilled within 1 day with a profit of $0.14 (6.54%) receiving and performance score of 65.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Nov-2025
$85
$22.01 (34.94%)
$110
5 days ago
(05-Mar-2026)
13/17 (76.47%)
$20.68 (32.15%)
45
Hold Since 12-Feb-2026
$70
$7.01 (11.13%)
$120
26 days ago
(12-Feb-2026)
20/38 (52.63%)
$10.35 (17.35%)
174
Buy Since 13-Apr-2020
$85
$22.01 (34.94%)
$165
26 days ago
(12-Feb-2026)
21/29 (72.41%)
$25.35 (42.50%)
187
Buy Since 13-Apr-2023
$85
$22.01 (34.94%)
$130
26 days ago
(12-Feb-2026)
7/14 (50%)
$25.35 (42.50%)
51
Hold Since 22-Sep-2025
$91
$28.01 (44.47%)
$89
2 months 15 days ago
(23-Dec-2025)
6/11 (54.55%)
$-3.98 (-4.19%)
189
Which stock is Frank Takkinen is most bullish on?
Which stock is Frank Takkinen is most reserved on?
What Year was the first public recommendation made by Frank Takkinen?
